Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.